NY authorities say $170M pill ring shut down

Authorities say they've shut down several New York City medical clinics and arrested two dozen people in a scheme to sell more than 5 million prescription painkillers on the black market.

The arrests were announced on Wednesday by the U.S. attorney's office in Manhattan and the New York City special narcotics prosecutor.

Investigators say the pill ring relied on corrupt physicians who wrote thousands of unnecessary prescriptions for highly addictive oxycodone since 2011. They say the 5 million pills had a street value of at least $170 million.

Prosecutors say unruly crowds of people formed each morning at a Bronx clinic to pay up to $300 to see a doctor, who would then give them oxycodone prescriptions without doing exams.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Sales of oxycodone by doctors fall in Florida

Feb 02, 2012

The number of oxycodone pills sold by Florida doctors dropped dramatically in 2011, following a series of high-profile arrests and a legislative crackdown on the storefront "pill mills" that made South Florida the hub of ...

DEA settles Walgreens painkiller case for $80M

Jun 11, 2013

The U.S. Drug Enforcement Administration has reached an $80 million civil settlement with the Walgreens pharmacy chain over violations of rules governing the distribution of powerful prescription painkillers.

Deaths from painkiller overdose triple in decade

Nov 01, 2011

The number of overdose deaths from powerful painkillers more than tripled over a decade, the government reported Tuesday - a trend that a U.S. health official called an epidemic, but one that can be stopped.

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

Jul 24, 2014

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

User comments